Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McCarthy

Showing results (341-350 of 369) with videos related to

Pageof 37
Sort By:
Current Molecular Medicine|May 12, 2010
CSPG4 in cancer: multiple rolesX Wang, Y Wang, L Yu, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|February 21, 2017
Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesisS B Bahrami, C Tolg, T Peart, et al.
Cancers|May 28, 2020
Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast CancerPatrice M Witschen, Thomas S Chaffee, Nicholas J Brady, et al.
Cancers|September 26, 2020
Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. <i>Cancers</i> 2020, <i>12</i>, 1325Patrice M Witschen, Thomas S Chaffee, Nicholas J Brady, et al.
The American Journal of Pathology|August 15, 2012
A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin woundsCornelia Tolg, Sara R Hamilton, Ewa Zalinska, et al.
Journal of Occupational and Environmental Medicine|September 7, 2021
Proposed Mitigation and Adaptation Strategies Related to Climate Change: Guidance for OEM ProfessionalsIsmail Nabeel, Yohama Caraballo-Arias, William Brett Perkison, et al.
Frontiers in Oncology|March 14, 2022
Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in <i>TP53</i>-Aberrant Triple-Negative Breast CancerZhe-Yu Hu, Chanjuan Zheng, Jianbo Yang, et al.
Carcinogenesis|August 2, 2011
NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinomaWenjuan Li, Xiaoling Li, Wei Wang, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 12, 2014
Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancerSuniti Misra, Shibnath Ghatak, Alok Vyas, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1982
Implantable insulin pump: insulin infusion in animals and manH Buchwald, W M Rupp, T D Rohde, et al.
Pageof 37

Showing results (341-350 of 369) with videos related to

Sort By:
Pageof 37
Current Molecular Medicine|May 12, 2010
CSPG4 in cancer: multiple rolesX Wang, Y Wang, L Yu, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|February 21, 2017
Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesisS B Bahrami, C Tolg, T Peart, et al.
Cancers|May 28, 2020
Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast CancerPatrice M Witschen, Thomas S Chaffee, Nicholas J Brady, et al.
Cancers|September 26, 2020
Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. <i>Cancers</i> 2020, <i>12</i>, 1325Patrice M Witschen, Thomas S Chaffee, Nicholas J Brady, et al.
The American Journal of Pathology|August 15, 2012
A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin woundsCornelia Tolg, Sara R Hamilton, Ewa Zalinska, et al.
Journal of Occupational and Environmental Medicine|September 7, 2021
Proposed Mitigation and Adaptation Strategies Related to Climate Change: Guidance for OEM ProfessionalsIsmail Nabeel, Yohama Caraballo-Arias, William Brett Perkison, et al.
Frontiers in Oncology|March 14, 2022
Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in <i>TP53</i>-Aberrant Triple-Negative Breast CancerZhe-Yu Hu, Chanjuan Zheng, Jianbo Yang, et al.
Carcinogenesis|August 2, 2011
NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinomaWenjuan Li, Xiaoling Li, Wei Wang, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 12, 2014
Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancerSuniti Misra, Shibnath Ghatak, Alok Vyas, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1982
Implantable insulin pump: insulin infusion in animals and manH Buchwald, W M Rupp, T D Rohde, et al.
Pageof 37